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Abstract: A current advance in nanotechnology is the selective targeting of therapeutics by
external magnetic ﬁeld-guided delivery. This is an important area of research in medicine. The
use of magnetic forces results in the formation of agglomerated structures in the ﬁeld region.
The transport characteristics of these agglomerated structures are explored. A nonintrusive
method based on in situ light-scattering techniques is used to characterize the velocity of such
particles in a magnetic ﬁeld gradient. A transport model for the chain-like agglomerates is
developed based on these experimental observations. The transport characteristics of magnetic
nanoparticle drug carriers are then explored in gel-based simulated models of the brain. Results
of such measurements demonstrate decreased diffusion of magnetic nanoparticles when placed
in a high magnetic ﬁeld gradient.
Keywords: nanoparticle ferroﬂuid, gel-brain model, drug delivery, magnetic agglomeration,
transport, magnetic ﬁelds

Introduction
The ability to precisely target and control the release of a drug to any tissue or region
in the body with great speciﬁcity is an important objective of therapeutic delivery.
Systematic research over the past few decades has been performed to use magnetic
ﬁelds to steer and target drugs using ferroﬂuids that can reversibly bind therapeutic
agents.1,2 The concept of magnetically guided targeted drug delivery is simple, wherein
the drug of choice is bound to a particle with a magnetic core, and an external magnet is
used to guide the composite to the desired point in the body and/or deposit in a certain
location for controlled release of the drug. Many studies have been done to examine
the targeting of therapeutics in animal models.3,4 Lubbe and colleagues5 were the ﬁrst
group to perform a clinical trial using magnetic drug targeting in a small population of
14 patients with advanced solid tumors. Hafeli6 has highlighted the requirement of
a large and precisely deﬁned magnetic ﬁeld gradient, as well as the need for the use
of small sized particles with a high magnetic susceptibility. Though larger sized
particles experience a higher magnetic force (magnetic moment is proportional to the
third power of diameter), they are also cleared more rapidly from the blood by the
body’s reticulo-endothelial system (RES).7 Mykhaylyk and colleagues8 suggested that
particles should be smaller than 400–500 nm, and perhaps even as small as 150 nm to
avoid fenestrations in the liver and spleen. Thus, ﬁnding an optimal size is essential
and ideal carriers should be as large as possible (to experience larger magnetic forces)
but small enough to move into the desired target region and avoid clearance.
The capacity to direct therapeutic agents to speciﬁc areas in the brain is important
in the treatment of a number of diseases such as Parkinson’s disease and cancer.9
Much of the current research in this area centers on convection-enhanced delivery
(CED), which utilizes positive pressure infusion directly into the target site, but lacks
speciﬁcity of the volume of distribution.10,11 The combination of CED and use of
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magnetic forces to enhance targeting may enable delivery of
particles to speciﬁc regions or help restrict the particles within
pre-deﬁned boundaries, thus, effectively reducing clearance
and minimizing adverse interactions with healthy tissue.12–14
To accomplish this, the magnetic force generated on the
particles would need to be sufﬁcient to overcome diffusion
and convective ﬂow in the brain. The use of chaining and
the creation of particle agglomerates for therapeutic delivery
has been reported by Forbes.12 They used superparamagnetic
particles that agglomerated in the magnetic ﬁeld gradient, and
thus overcame convective and diffusive forces to remain in
the blood vessel and eventually deposit on the walls.
To effectively develop such a system, it is important
to evaluate the transport characteristics by understanding
the various forces acting on the particles. The velocity of
the nanoparticles are dependent on the magnetic and drag
forces that act on the particles.13 An additional complexity
that needs to be accounted for is that magnetic particles tend
to agglomerate in a magnetic ﬁeld gradient and create larger
chain-like structures.14–17 If the force balance calculations
are done based on single particle analysis,18,19 the effective
magnetic force and velocity of the particles will be underpredicted. While there have been experimental demonstrations
of such strategies,20 no detailed studies have been conducted
to develop an understanding of the increased magnetic forces
due to agglomeration and the reduction of transport.
This paper reports a detailed evaluation of velocity of
magnetic particles undergoing simultaneous agglomeration in
a magnetic ﬁeld gradient. The change in morphology (shape) of
the resultant agglomerate is accounted for in the evaluation. The
ﬁrst experiment evaluated the velocity by monitoring the particle
agglomeration state using in situ light-scattering measurements.
The second set of experiments demonstrated the formation
of such chain-like structures in a gel model of the brain, and
demonstrated the potential for targeted delivery by overcoming
convective and diffusive forces. A theoretical model is developed
to estimate the agglomeration of magnetic nanoparticles and
calculate the effective force acting on the nanoparticles due

to the change in effective size. The model is used to explain
the potential of developing a process for locking magnetic
nanoparticles in a certain region after infusion into the brain.

Materials and methods
Ferrofluids used
A ferroﬂuid is a liquid composed of nanoscale ferromagnetic
or ferrimagnetic particles suspended in a carrier ﬂuid, usually
an organic solvent or water. Often these particles are coated
with organic polymers like polyethylene glycol (PEG) to
prevent agglomeration and improve surface functionality for
potential multimodal biomedical applications. Two types of
nanoparticles with different sizes, morphologies and magnetic
properties suspended in water were used in this study to create
the ferroﬂuid. The ﬁrst nanomaterial was clustered Fe3O4
encapsulated in a biodegradable polymer matrix (PEG-300,
MicroMod Partikeltechnologie GmbH, Germany). Two different
sizes, 130 nm (Product No. 09-54-132) and 250 nm (Product No.
09-54-252) were used. The second nanomaterial was 110 nm
pure uncoated cupro-spinel (CuFe2O4) particles synthesized
by spray pyrolysis in a furnace aerosol reactor starting with a
1:2 molar ratio of premixed CuSO4 and Fe(NO3)3 in aqueous
solution. Details of the synthesis method are provided in the
supporting document section. The concentration of particles was
diluted using double deionized water to 1 mg ml−1 calculated
based on total solid mass of the nanoparticles for all the
experiments unless otherwise mentioned. Other characteristics
of the particles used are listed in Table 1.

Experimental setup to estimate
the velocity of nanoparticles
in a magnetic field gradient by an in situ
light-scattering technique
A permanent magnet (7.62 × 10.16 × 12.70 cm) was utilized
to create the magnetic ﬁeld gradient by using the equipolar
xy-plane on a nonpole face of the magnet. The change in magnetic ﬂux density and magnetic ﬁeld gradient as a function of

Table 1 Size and magnetic properties of nanomaterials used
Material

Mean primary
particle size (nm)

Composition

Density
(kg m−3)

1

250

PEG-coated
Fe3O4

a

2

130

PEG-coated
Fe3O4

a

3

110

CuFe2O4

b

Moment
(emu gm−1 @ 1 kOe)

2500

a

3000

a

5400

c

Saturated moment
(emu gm−1 @ 10 kOe)

χv (Volumetric magnetic
susceptibility @ 1 kOe)

67.0

1.351

67.0

1.621

38.6

1.866

43.0

a

43.0

a

27.5

c

Notes: aSupplied by MicroMod Partikeltechnologie GmbH (Germany); bBulk density; cMeasured using Physical Property Measurement System (PPMS, Model: 6000, Quantum
Design).
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distance from its surface was measured by a Lakeshore 421
Gauss meter with MMA-2502-VH Hall probe (Figure S2).
The velocity of the particles in the magnetic ﬁeld gradient
were measured in an aqueous suspension using an in situ
static light-scattering technique similar to that described by
Kulkarni and colleagues.20 The optical system is comprised
of a tungsten-ﬁlament lamp, a 455 nm ﬁlter, lenses and
apertures to focus the light, along with a detector placed
at 90° with respect to incident beam to monitor scattered
light (Figure 1). 20 ml ferroﬂuid (1 mg ml−1) was placed in
a Borosilicate glass sample cell (9.5 cm high × 2.5 cm inner
diameter) with rubber-lined screw caps. The magnet was
placed below the sample cell at different distances to vary
the magnetic ﬁeld gradient. The intensity of the scattered
light was measured at 10s time intervals after imposition
of the magnetic ﬁeld gradient. The scattering intensity was
measured at three different ﬁeld gradients (4.1, 3.6, and 2.0
T m−1) and this varied due to collision and agglomeration of
particles. Three to ﬁve measurements were taken for each
ferroﬂuid at each magnetic ﬁeld gradient for statistically
relevant results. The travel path length for the ferroﬂuid
material was kept constant (1.1 cm) and the mean time to
traverse the path was estimated from the time taken to lose
50% of the scattering intensity (midpoint of the slope of the
normalized scattering intensity versus time plot). The average
velocity (ve) of the particles in the ferroﬂuid was calculated
by dividing the path length traversed by the mean time taken.
Based on the experimentally determined velocity of the
ferroﬂuid particles in the magnetic ﬁeld gradient, a theory

is proposed to estimate the average number of particles in
single agglomerate, and to calculate the effective magnetic
force exerted on the nanoparticle agglomerates.
To support the formation of a chain-like agglomerated
structure in the presence of a magnetic ﬁeld, scanning electron microscope (SEM, model Hitachi S4500) images were
taken of the particles. The SEM samples were prepared by
taking 0.5 ml of ferroﬂuid on a SEM mount (Ted Pella Inc.,
product ID 16202). The SEM mount was then placed in a
magnetic ﬁeld gradient and kept for 24 hr to evaporate the
solvents. The dry nanoparticles on the SEM mount were
imaged to analyze the morphology.

Experimental setup to establish
the transport of particles in a gel model
using light microscopy
The understanding of particle transport characteristics gained
in the preceding experiments was applied to study particle
transport behavior in a gel model of the human brain. A 0.6%
agarose gel was selected as the in vitro model for the experiment, and has been previously validated by infusion experiments within a porcine brain.21 In those experiments, the gel
was found to have a distribution to infusion volume ratio
28% greater than the porcine brain; with the conclusion made
that the gel’s hydraulic conductivity was roughly 1/3 greater
than that of the brain.21 Measurements of inter-ﬁber distance
from electron micrographs22 show a distance of 480 nm for
a 0.6% agarose gel.

90° scattered
light detector
Tungsten
filament lamp

Aperture

Sample cell
Lens
Filter
(455 nm)
Figure 1 Experimental setup to study the transport characteristic of the ferrofluid in a controlled environment. The magnet was placed below the sample cell at different
distances to vary the magnetic field gradient.
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Incidental observation of ferroﬂuid in the presence of
the magnetic ﬁeld gradient suggested that strong magnetic
ﬁelds might hinder transport of nanoparticles within the gel
due to particle agglomeration. Therefore, an experiment was
devised to assess the effects of the magnetic ﬁeld gradient
on transport of magnetic nanoparticles inside the pores of
a gel. The gel was made by mixing agarose powder (Sigma
Aldrich, St. Louis, MO) with 1 X TBE as described by Chen
and colleagues21 and heating in the microwave until fully
dissolved. The gel was removed, allowed to cool for ﬁve
minutes and placed into 15 ml plastic test tubes.
A microinjection pump and polyethylene tubing
(Intramedic) with 1.22 mm outside diameter was used to
infuse 1 mg ml−1 of 250 nm particles (material 1) suspended in
water into the test tubes ﬁlled with 3 ml of gel. A total of 10 μl
of infusate was delivered at a rate of 2 μl min−1 into the gel.
1 ml of deionized water was placed onto the top of the gel to
prevent dehydration and provide a small hydrostatic pressure
to enhance transport. Four gels were placed onto the magnet
with the bottom of the test tube resting above the pole of the
magnet, with the vertical axis in the direction of the ﬁeld lines.
For the high ﬁeld experiment, the particles were exposed to
a gradient of 8.0 T m−1 while in the low ﬁeld experiment the
particles experienced a gradient of 0.55 T m−1. The control
group consisted of four gels placed outside of the magnetic
ﬁeld gradient in the same vertical orientation as the experimental gels.
An image of each gel was taken after infusion of the
ferroﬂuid and the orientation of the test tube, along with its
position in the ﬁeld, was recorded to ensure reproducibility.
Images were obtained via a Zeiss light microscope equipped
with a Dage-MTI CCD-72 camera. At the lowest power
objective, a resolution of approximately 5 μm pixel−1 was
achieved. An image from each gel and time point was
inverted so that the dark particles corresponded to higher
pixel values than the background. The mean and median pixel
value of each image was then calculated for a 625 × 415 pixel
area. The mean and median pixel value was then normalized
for each gel, with the 0 hr value set as the baseline. All
images were analyzed with NIH ImageJ Version 1.36b. It
is important to note that while the gels resided for most of
the experiment in the vertical plane, the microscope setup
required that they be turned horizontally to be imaged. Gels
were removed from the magnet and control area for imaging
at 3, 6, and 16 hours and then every 16 hours after that until
the 48 hour mark. The experiment was repeated with the
130 nm particles (material 2) placed in both the high ﬁeld
and the low ﬁeld regions along with the control group.

12

Results and discussion
A theory is proposed to estimate the particle agglomeration
and effective force taking into account the agglomerated
chain-like structure. The velocity of nanoparticles in an
external magnetic ﬁeld gradient was determined by a static
light-scattering technique. The experimentally measured
velocity was used to estimate the effective particle size due
to chaining based on the proposed theory. The transport of
nanoparticles in a gel model was then established.

Theoretical estimation of particle
agglomeration and effective force acting
on particles in ferrofluid in magnetic field
gradient
Two forces act on a single nanoparticle suspended in a ﬂuid
medium in the magnetic ﬁeld gradient – the magnetic force
and the drag force. The terminal velocity (vt,1) in a magnetic
ﬁeld gradient can be readily obtained based on a single particle force balance as reported by Holligan and colleagues18
and Kuhn and colleagues19
vt , l =

χ v δΒ 2 d p 2
36ημ0

(1)

where, χv is the volumetric magnetic susceptibility of
the nanoparticle, δΒ is the magnetic ﬁeld gradient, dp is the
mean diameter of the primary nanoparticle, η is the viscosity
of the ﬂuid medium into which the particles are injected, and
μ0 is the permeability of free space.
However, when placed in a magnetic ﬁeld gradient, the
ferromagnetic particles in the ferroﬂuid interact with each
other and form agglomerated structures. The morphology
of these agglomerates formed by collision of nanoparticles
in an external magnetic ﬁeld gradient typically results in a
chain-like structure. Thus the terminal velocity calculated
based on the force balance on a single particle is expected
to under predict the actual velocity of the particles due to a
change in the effective size (that will alter both the magnetic
force and the drag force). To account for the chaining of
nanoparticles due to collisions in the magnetic ﬁeld gradient, a modiﬁed magnetic force and drag force expression is
proposed. Assuming each chain-like agglomerate is made
up of an average of “n” number of primary particles with
mean diameter dp, the modiﬁed magnetic force (Fm,c) can
be given by,
Fm, c =

nπ χ v δΒ 2 d p 3
12 μ 0

(2)
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The drag force on a nonspherical structure can be
estimated by extending the Navier–Stokes equation for drag
on an isolated sphere in creeping ﬂow.23–25 A detailed drag
force expression proposed by Leith25 for nonspherical shape
particles is used to estimate the drag force on the chain-like
magnetic nanoparticle agglomerate (Fd,c),
⎛ 1 2 dn ⎞
Fd , c = 3 π η vt , c dn ⎜ +
⎝ 3 3 ds ⎟⎠

(3)

where vt,c is the terminal velocity for a chain-like structure,
dn is the diameter of the sphere with same projected area
as the area of the particle projected normal to its direction
of motion, ds is the diameter of the sphere whose effective
surface equals that of the particle. For a chain-like structure
formed by agglomeration of “n” particles in a linear manner
with mean diameter of each primary particle being dp, dn
can be replaced with dp and ds can be replaced by n1 / 2 d p .
Thus the drag force for a chain-like structure (Eq. 3)
becomes
⎛1 2
⎞
Fd , c = 3 π η vt , c d p ⎜ +
n⎟
⎝3 3
⎠

(4)

The terminal velocity for a chain-like structure (vt,c) in
a magnetic ﬁeld gradient can be calculated by equating the
modiﬁed magnetic force (Eq. 2) to drag force (Eq. 4) as

vt , c =

χvδ Β 2 d p 2 ⎛ 3 n ⎞
⎛ 3n ⎞
⎜
⎟ = vt ,l ⎜
⎟
36ημ0 ⎝ 1 + 2 n ⎠
⎝1+ 2 n ⎠

The equation for the number of primary particles in an
agglomerate can be further simpliﬁed as
n=

1/ 3

β FM =

2
2 ⎡ π χi χ j B ⎤
⎥
4/3 ⎢
3 ⎢⎣ μo
⎥⎦

( k B T )1 / 6

1
( di d j )
p p1 / 2

1/ 2

⎡ 1
1 ⎤
⎢ 3 + 3⎥
d j ⎥⎦
⎢⎣ di

(8)

( di + d j )

where B is the magnetic ﬂux density, kB is the Boltzmann
constant, T is the temperature, and ρp is the density of the
nanoparticles. The expression for the collision frequency
function (Eq. 8) can be further simplified based on a
monodisperse particle assumption (ie, di = d j = d p and
χi = χ j = χ v )
1/ 3

β FM

4 ⎡π χ Β 2 ⎤
= 4/3 ⎢ v ⎥
3 ⎣ μ0 ⎦

(2k BT )1 / 6

12 ⎡⎢ vt , cημ0 (24 vt , cημ0 + δΒ 2 d p 2 χ v ) + 4 3 vt , c 3η 3 μ0 3 (12vt , cημ0 + δΒ 2 d p 2 χ v ) ⎤⎥
⎦
n= ⎣
δΒ 4 d p 4 χ v 2
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where ξ is a dimensionless magnetic velocity enhancement
factor given as vt , c /vt , l . The estimated number of primary
particles in an agglomerate (Eq. 6 or 7) can be used to calculate the effective force acting on a chain-like agglomerate
using Equation 2.
The proposed theory based on creeping flow of a
nonspherical shape particle falls within the laminar ﬂow region
of Reynolds number calculated based on experimental velocity
and mean agglomerate particle size. The use of average n number of primary particles in a chain-like structure to calculate
the effective magnetic force can be justiﬁed by comparing
the characteristic time to form the chain-like morphology
with that required to attain the terminal velocity in a magnetic
ﬁeld gradient. The characteristic time for terminal velocity in
a magnetic ﬁeld gradient (τm) is calculated by estimating the
time to travel a distance of 1 cm, based on a single particle
force balance. The characteristic time for forming chain-like
structures due to collisions in a magnetic ﬁeld gradient can
be estimated by an analytical expression given by Kumar
and colleagues.26 Assuming the interacting particles form
a chain-like agglomerate in a magnetic ﬁeld gradient, the
collision frequency function in the free molecular regime
(βFM) is given by

(5)

Based on proposed derivation, it is clear, that the terminal velocity for a chain-like agglomerated structure is
enhanced by a factor dependent on the number of primary
particles in the agglomerate. The theoretically calculated
terminal velocity in the magnetic ﬁeld gradient based on
single particle force balance always underestimate the
actual velocity of particles in the presence of an external
magnetic ﬁeld gradient. Furthermore, the expression for the
terminal velocity for a chain-like structure (Eq. 5) can be
solved to estimate the average number of primary particles
in agglomerate as

1⎡
ξ (3 + 2 ξ ) + 2 ξ 3 (3 + ξ ) ⎤
⎦
9⎣

1

ρ p1 / 2

d p3 / 2

(9)

(6)
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The characteristic time for magnetic coagulation (τc) can
then be calculated as τ c = 1/(Ν o β FM ), where No is the initial
concentration of nanoparticles.

Experimental measurement of velocity
of particles in a ferrofluid in a magnetic
field gradient by in situ static light
scattering technique: Estimation
of chaining and effective magnetic force
The intensity of scattered light for the 110 nm ferroﬂuid was
normalized to initial time (t = 0 s) and plotted against time
(Figure 2). There are two clearly distinguishable plateaus that
can be identiﬁed in this ﬁgure. The decrease in normalized
intensity (normalized at t = 0 s) followed by the plateau at
t ⬍ 100 s is thought to be caused by changes in the morphology
of the agglomerated particles due to the external magnetic
ﬁeld gradient (Figure S3). When initially placed in a magnetic
ﬁeld gradient, the particles tend to form an ordered chain-like
morphology compared to its initial random unagglomerated
morphology. A drop in scattering intensity is expected due
to this morphology change that results in a decrease in the
particle number concentration. The continued decrease in
normalized intensity (normalized at t = 100 s) followed by
the second plateau at t ⬎ 100 s results from a decrease in the
absolute concentration of the particles due to magnetic mobi-

lization and settling of the ferroﬂuid particles (Figure S4).
The drop in scattering intensity due to formation of chain-like
structures due to collision of particles in the magnetic ﬁeld
gradient is a reversible process (on removal of ﬁeld), while
the drop in scattering intensity due to settling is irreversible
(loss of particles from view volume). The time scale (τc) to
reorganize the morphology by collision of particles for all
materials in different external magnetic ﬁelds were theoretically calculated and plotted in Figure 3 based on the properties
of the materials listed in Table 1. The calculated characteristic
time for agglomeration due to collisions was found to be on
the order of ∼10−3 s, which is similar to the experimentally
measured value by Fernandes and colleagues.27 The estimated
characteristic time for velocity (τm) in an external magnetic
ﬁeld gradient is on the order of ∼103 s (Figure 3). The order
of magnitude analysis of the characteristic time for agglomeration by collisions and particle velocity clearly justiﬁes the
use of a chain-like structure to estimate the true velocity of
chain-like agglomerates. It also suggests that the two plateaus
found in the plot of normalized scattering intensity versus
time (Figure 2) are caused by two different phenomena: the
ﬁrst one due to collisional growth in magnetic ﬁelds, while
the second one is due to settling under the inﬂuence of the
magnetic ﬁeld gradient. The same trend is seen in the plot
of initial normalized scattering intensity versus time for the
other two materials (Figures S5 and S6).

Normalized scattering intensity

1.0

2.0 T m–1
3.6 T m–1
4.1 T m–1

0.8

0.6

0.4

0.2

0.0
0

200

400

600

800

Time (s)
Figure 2 Variation of normalized scattering intensity (normalized at t = 0s) with time for material 3 (110 nm ferrofluid) at various applied magnetic field gradient.
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Characteristic time (s)

1e + 8

τc – 250 nm

1e + 7

τm – 250 nm

1e + 6

τc – 130 nm

1e + 5

τm– 130 nm

1e + 4
1e + 3

τc – 110 nm
τm – 110 nm

1e + 2
1e + 1
1e + 0
1e – 1
1e – 2
1e – 3
1e – 4
1e – 5
4.1

3.6

2

Magnetic field gradient (T m–1)
Figure 3 Comparison of characteristic time of collisional growth in magnetic field (τc) and characteristic time to traverse 1 cm (τm) for different ferrofluids at various magnetic field gradients.

Variation of scattering intensity normalized to t = 100 s
(Figure S3) is used to estimate the velocity of 110 nm particles
in the external magnetic ﬁeld gradient listed in Table 2.
Similarly, the velocity of 130 nm and 250 nm particles
in the ferroﬂuid is estimated from the plot of scattering
intensity normalized to t = 30 s (Figure 4). The scattering intensity normalized to t = 0 s for these materials are
provided in Supporting information (Figures S5 and S6).
A different time is used to normalize the scattering intensity
for the 130 nm and 250 nm ferroﬂuid (t = 30 s) compared
to 110 nm ferroﬂuid (t = 100 s). The time is chosen based
on experimental measurements close to the actual position

of the ﬁrst plateau. The properties of the materials listed
in Table 1 are used in equation 1 to theoretically predict
the terminal velocity based on a single particle force balance in water in the presence of an external magnetic ﬁeld
gradient (Table 2). A plot of the experimentally measured
and theoretically predicted velocity as a function of the
magnetic ﬁeld gradient is shown in Figure 5. It is of note that
the experimentally measured velocity exceeded the predicted
values by as little as a factor of ∼3 and as much as a factor of
∼10. This is attributed to the agglomeration of particles while
in the magnetic ﬁeld gradient, giving the particles a larger
effective size and therefore experiencing a larger effective

Table 2 Experimental matrix to study the transport characteristic of different ferrofluid in controlled environment
Material

1

2

3

Magnetic field gradient
(T m−1)

Particle velocity (cm s−1)

ve/vt

Estimated number of
primary particles in
each agglomerate (n)

Experimental (ve)

Theoretical (vt,1)

4.1

−2

1.0 × 10

3.5 × 10−3

3.0

6

3.6

8.5 × 10−3

2.7 × 10−3

3.1

6

−4

2.0

5.2 × 10

8.6 × 10

6.1

22

4.1

4.6 × 10−3

1.1 × 10−3

4.0

10

3.6

3.3 × 10

8.8 × 10

3.8

9

2.0

2.0 × 10

2.8 × 10

7.3

32

4.1

4.6 × 10

9.5 × 10

4.8

14

3.6

3.3 × 10

7.2 × 10

4.6

13

2.0

2.3 × 10−3

2.3 × 10−4

10.0

58
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−3
−3
−3
−3

−4
−4
−4
−4
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A
1.2
2.0 T m–1
3.6 T m–1

Normalized scattering intensity

1.0

4.1 T m–1

0.8

0.6

0.4

0.2
100

200

300

400

500

600

700

800

900

Time (s)

B
1.2
2.0 T m–1
3.6 T m–1

Normalized scattering intensity

1.0

4.1 T m–1
0.8

0.6

0.4

0.2

0.0
100

200

300

400

500

600

700

800

900

Time (s)
Figure 4 A) Variation of normalized scattering intensity (normalized at t = 30 s) for material 2 (130 nm ferrofluid) at various applied magnetic field gradient. B) Variation of
normalized scattering intensity (normalized at t = 30 s) for material 1 (250 nm ferrofluid) at various applied magnetic field gradient.
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Figure 5 Comparison of experimentally measured velocity (ve) with theoretically predicted velocity based on single particle force balance (vt,1) for different ferrofluid at
various magnetic field gradients.

magnetic force. The experimentally measured velocity at a
ﬁxed magnetic ﬁeld gradient is a function of mean primary
particle size; hence, the velocity is higher for bigger particles.
Further, for same particle sizes, the velocity is a function
of the applied magnetic ﬁeld gradient. These ﬁndings are
consistent with the proposed model of force balance on
chain-like agglomerates.
The experimentally estimated velocities were used to
estimate the average number of primary particles in each
chain-like agglomerate based on Equation 6. The effective
force acting on the agglomerates was determined using
Equation 3 (Table 2). The number of primary particles
in the agglomerate (n) was found to be a function of the
magnetic ﬁeld gradient, the primary particle size, and its
underlying material composition. The number of primary
particles in an agglomerate decrease as the magnetic ﬁeld
gradient and mean primary particle size increases. The
uncoated nanoparticle (material 3) was found to form larger
agglomerates compared to the similar sized PEG-coated
material (material 2). High resolution scanning electron
micrographs were taken of all materials and provided
direct evidence of chaining. Figure 6 shows the difference
in particle alignment and distribution after drying inside
and outside the high magnetic ﬁeld gradient region. The
particles that dried outside the magnetic ﬁeld gradient

International Journal of Nanomedicine 2009:4

appear in a more random orientation, while those dried in
the ﬁeld appear to chain and an agglomerate. The effective
magnetic force is higher than the force calculated without
any agglomeration by a factor n. As the number of primary
particles in agglomerate is found to have an inverse relation
with the applied magnetic ﬁeld gradient, it can be concluded
that even a small magnetic ﬁeld gradient can generate
a very high effective force on magnetic nanoparticles due
to enhanced agglomeration.

In vitro transport characteristic
of ferrofluid in a gel model of the brain
using light microscopy
After taking images of the test tubes at 0, 3, 6, 16, 32, and
48 hours, the data was analyzed and normalized with ImageJ.
The normalized pixel values for each series of gels at a given
time point was averaged and the results displayed in Figure 7.
The inherent assumption in this analysis is that a higher concentration of particles in an image, whether they are in or out of the
plane of focus, will contribute to a higher average pixel value.
Therefore, the mean pixel value was used as a proxy for total
particle concentration in a given image. As particles diffuse
away from the original infusion site, the overall concentration
of particles for any given area of the image will decrease, leading to a lower mean pixel value. The results in Figure 7 suggest
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Figure 6 SEM images of different ferrofluids in the absence or presence of an external magnetic field.

that the highest magnetic ﬁeld gradient (8.0 T m−1) retains
more particles in the image. As the ﬁeld strength decreases,
the loss in average pixel value over time indicates diffusion
of particles for both the materials. However, it is to be noted
that, even a ﬁeld as small as 0.55 T m−1 can be partially effective to hinder the free diffusion of the nanoparticle due to

higher effective size as a result of collisional growth in the
magnetic ﬁeld gradient. One way to validate the above data
is to examine the histograms of pixel values in the image over
time (Figure S7). Initially stratiﬁed across the spectrum of pixel
values, after 48 hours the control gel appears to converge, most
likely onto the background (baseline) value. The gel exposed
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Figure 7 Plot of average normalized pixel values for gels with different size particles as a function of time and external magnetic field gradient.
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to the magnetic ﬁeld gradient however retains a remarkably
similar distribution to the 0 hour histogram. This would seem
to indicate that the particles remain concentrated in the presence of the magnetic ﬁeld gradient, in agreement with the data
in Figure 7. Further, the decrease in normalized pixel value
for 250 nm particles is greater compared to 130 nm particles
at the same applied ﬁeld, which may be an artifact of the
experiments. Since the experiment is designed with the same
initial concentration of ferroﬂuid (1 mg ml−1), the number
concentration of the 130 nm sample is higher compared to the
250 nm samples. Due to higher overall projected surface area,
the 130 nm sample contributes more towards the pixel value
than the same amount of 250 nm sample.
Unfortunately, due to our desire to utilize the same particles
analyzed in the experiments for velocity measurements,
diffusion analysis was not done with one of the more accepted,
and analytically rigorous methods proposed in the literature,
such as ﬂuorescence recovery after photobleaching (FRAP).28,29
Because of this, transport of particles in the gels is compared
only qualitatively using an optical imaging technique. However,
the proposed model clearly indicates that particles with a larger
effective size will experience signiﬁcant reductions in transport
(diffusivity) in the magnetic ﬁeld gradient due to agglomeration.
The assertion that the particles are agglomerating is supported
by the SEM results (Figure 6), as well as the high magniﬁcation
light microscope results (Figure S8).
The results described seem to indicate that bulk ﬂow of
particles due to magnetic ﬁelds, as demonstrated by Kuhn and
Holligan at 45.0 T m−1, does not occur in our in vitro model
at gradients less than 10.0 T m−1. However, Goodwin4 noted
that after a two hour magnetic exposure, the distribution
of particles remained approximately the same for at least
a further two hours after removing the magnet, indicating
hindered diffusion. Goodwin’s ﬁndings4 agree with the results
of the diffusion experiments outlined above. The effective
size of the particles is drastically increased by collisional
growth forming a chain-like agglomerate as demonstrated
in previous sections. Therefore, in our experiments the
agglomerate of particles appears to diffuse much more slowly,
hindering the diffusion of particles. The dependence of size
on diffusivity has been conﬁrmed with various in vivo and
in vitro studies.11,30,31 Ohata and colleagues28 demonstrated that
diffusion plays a role in spread of macromolecules through
the cortex, and this phenomenon is dependent on size. In fact,
Kuhn19 characterized the movement of superparamagnetic
nanoparticles through extracellular matrix from murine
sarcoma and found that the velocity of 135 nm particles was
more than 100 times that of 400 nm particles.
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This has tremendous implications for therapeutic use in
the brain. In theory, small magnetic nanoparticles, approximately 50 nm or below, could be infused via CED to cover
a large percentage of the intended target, as demonstrated by
Muldoon.29 Then, the particles might be effectively locked
into place by exposing the region to a high magnetic ﬁeld
gradient. The resulting agglomeration due to collisions in
the magnetic ﬁeld gradient increase the effective size and
slow or prevent further passive diffusion of the particles.
If diffusion plays a dominant role in the clearance of the
particles, this could prove to be a method to signiﬁcantly
increase the local concentration. Even when diffusion is not
the primary mode of clearance, agglomeration within the
magnetic ﬁeld gradient could play a role by inhibiting the
convective process. Results from the velocity experiments
suggest that the agarose ﬁbers in a 0.6% agarose gel provide
an effective barrier to movement of particles greater than or
equal to 130 nm in diameter within a magnetic ﬁeld gradient.
Chen21 showed that the hydraulic conductivity was actually
greater in the agarose model than in porcine brain, which
suggests that the inability to move the nanoparticles might
also occur with the in vivo situation.
However, given the diffusion and conductivity differences
between different parts of the brain, the success of this
inhibition could vary depending on the area in which it is
deployed and the speciﬁc extracellular geometry of that
region. Conversely, if smaller particles are infused via CED, it
might be possible to maneuver them through the brain tissue
using magnetic ﬁelds. Muldoon and colleagues29 found that
60–185 nm ferumoxide particles did not leak into rat tumors,
while 20–50 nm particles did. The CED of 40 nm and 90 nm
liposomes into glioma xenografts was detailed by Mamot and
colleagues.11 The 40 nm liposomes were distributed throughout most of the tumor, and this effect was enhanced with the
addition of mannitol, causing the liposomes to spread beyond
the tumor boundaries. The 90 nm liposomes achieved just
over 50% coverage after the addition of mannitol, suggesting
that larger sizes reduced spread. The particle’s size, coating,
and magnetic properties will all be factors that could determine whether smaller particles aggregate and demonstrate
decreased diffusion, or whether the particles might be actively
moved with magnetic field manipulation. The gradient
strength could also be an important factor in determining the
tradeoff between these two possibilities.

Conclusions
A technique to determine the velocity of particles when a
ferroﬂuid is exposed to magnetic ﬁelds was established.
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It has been demonstrated that the velocity of magnetic
nanoparticles suspended in a ﬂuid medium when exposed
to a magnetic ﬁeld gradient is enhanced due to an increase
in effective size by collisional growth. A model was developed and used to estimate the effective size and the effective
magnetic force acting on the agglomerate based on force
balance on chain-like agglomerate structures. Further, it has
been demonstrated that magnetic nanoparticles greater than
or equal to 130 nm in diameter prove very difﬁcult to guide
through an in vitro model of the brain tissue. Result suggests
that low magnetic ﬁeld gradients (below 10 T m−1) could be
used to limit passive diffusion, and possibly slow convection
of nanoparticles within the brain due to agglomeration of
particles. This could have many therapeutic beneﬁts when
combined with convection enhanced delivery of magnetic
nanoparticles. Future work should be carried out with a
more quantitative approach to measuring diffusion, and an
in vivo model should be used to validate the results of the
agarose gel.

Acknowledgments
This work was partially supported by a grant from the
US Department of Defense (AFOSR) MURI Grant,
FA9550-04-1-0430 and the Center of Materials Innovation,
Washington University in St. Louis. David Brogan was
supported by an Alpha Omega Alpha Carolyn L. Kuckein
Student Research Fellowship.

Nomenclature and Greek
characters
B, magnetic ﬂux density (T); dn, diameter of the sphere with
same projected area as the area of the particle projected
normal to its direction of motion (m); dp, mean diameter of
primary nanoparticle (m); ds, diameter of the sphere whose
effective surface equals that of particle (m); Fd,c, drag force
acting on a chain-like agglomerate with n number of particles
of diameter dp (N); Fm,c, magnetic force acting on a chain-like
agglomerate with n number of particles of diameter dp (N);
kB, Boltzmann constant (J K−1); n, average number of primary
particles in each agglomerate; No, initial number concentration
of nanoparticles (# m−3); T, temperature (K); vt,1, terminal
velocity in magnetic ﬁeld gradient calculated based on single
particle force balance (m s−1); vt,c, terminal velocity of a chainlike agglomerate with n number of particles of diameter dp in
magnetic ﬁeld gradient (m s−1); βFM, the collision frequency
function in free molecular regime assuming the interacting
particles form a chain-like agglomeration in a magnetic
ﬁeld gradient (# s−1); δB, magnetic ﬁeld gradient (T m−1);

20

η, viscosity of the ﬂuid medium into which the particles are
injected (N s m−2); μo, permeability of free space; ξ, ratio of
terminal velocity in magnetic ﬁeld gradient calculated based
on force balance on chain-like structure to the velocity calculated based on force balance on single particle ( vt , c /vt , l ) ;
ρp, density of the nanoparticles (kg m−3); τc, characteristic
time for magnetic coagulation (s−1); τt, characteristic time for
terminal velocity (s−1); χv, volumetric magnetic susceptibility
of the nanoparticle.
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Supporting information
Experimental setup for nanoparticle
synthesis
The experimental setup for synthesis of nanocomposite
consisted of three components. A nebulizer was used as a
precursor feeding system, a tubular furnace aerosol reactor
(FuAR, Lindbergh BlueM model STF54779C, effective
length 106 cm and internal diameter 2.5 cm) was used to
decompose the precursor and an electrostatic precipitator
(ESP) was used for particle collection. Aqueous solution of
Fe(NO3)3 and CuSO4 (2:1 molar ratio) was nebulized and
carried by air into the FuAR and was decomposed at different temperatures (1000–1200οC). Air at different ﬂow rate

was used to provide an oxidizing atmosphere, and to control
the residence time inside the reactor. Precursor concentration (0.1–1 M) was varied to produce particles between
70–200 nm mobility diameter. The synthesized particles
were collected on a cylindrical ESP with applied potential
of +10 kV.
Particle mobility size distribution was measured at the
exit of FuAR using a scanning mobility particle sizer (SMPS,
Model: TSI 3936) system. The size and microstructures were
veriﬁed by a SEM (Model JEOL 7001LVF FE-SEM). The
crystallographic characteristics were analyzed by powder
XRD technique (Model: Rigaku D-MAX/A9 diffractometer,
Cu Kα radiation, λ = 1.5418 Å).
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Figure S1 Hysteresis loop for synthesized 110 nm CuFe2O4 at 300 K measured using a Quantum Design PPMS SQUID (model 6000).
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Figure S3 Variation of normalized scattering intensity (normalized at t = 0 s) due to magnetic coagulation for material 3 (110 nm ferrofluid) at various applied magnetic field gradient.
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Figure S4 Variation of normalized scattering intensity (normalized at t = 100 s) due to velocity for material 3 (110 nm ferrofluid) at various applied magnetic field gradient.
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Figure S5 Variation of normalized scattering intensity (normalized at t = 0 s) with time for material 2 (130 nm ferrofluid) at various applied magnetic field gradient.
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Figure S6 Variation of normalized scattering intensity (normalized at t = 0 s) with time for material 1 (250 nm ferrofluid) at various applied magnetic field gradient.
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Figure S7 Histograms of control gel infused with 130 nm particles at 0 hrs (a) and 48 hrs (b), and gel infused with 130 nm particles at (c) 0 hrs and (d) after 48 hrs in the
high magnetic field gradient (8.0 Tm−1).
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t = 0 hr

t = 23

Figure S8 Images of 110 nm particles (material 3) placed into middle of gel after punching with a needle before being placed into the magnetic field (left) and after 23 hours
in the magnetic field (right).
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